Refractory B-Cell Lymphoma Clinical Trials in L'Hospitalet de Llobregat, Barcelona

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology